Mexican research proposes alternative therapy against lung cancer

January 7, 2014, Investigación y Desarrollo

Research from the National Institute of Respiratory Diseases (INER) reveals that besides smoking, there are other factors associated with the development of lung cancer such as the smoke from burning lumber and coal, as well as pollutant particles.

"It has been considered that the upturn in cases of is possibly related to these particles", explains Patricia Gorocica from the INER, who, alongside her research team, has been working in an to boost the immune system of patients with this disease.

The specialist adds that for several years, it has been known that the immune system has all the mechanisms to monitor and destroy tumor cells as they develop, but sometimes these mechanisms are not effective for reasons associated with the tumor or changes in the patient's health.

Based on this principle, research at INER is focused on regulating the immune system against tumors. The tumors that can be more easily eliminated are the ones that express specific antigens.

Patricia Gorocica, chief of the Department of Biochemical Research at INER, says that with current technology, it is possible to manipulate the against tumors.

"We are developing at the lab a system of cell activation from the patient's own blood that can eliminate its tumors".

This is preliminary research, but it could be methodized as an alternative therapy for the patients with lung cancer. The labor is being done with the support of the institutes of Biotechnology and Chemistry of the Autonomous National University of Mexico (UNAM), hoping that others will add to the cause, since this research requires a multi-disciplinary team for succeeding.

Gorocica adds that manipulating the immune system could be a new complementary therapy to chemo- and radiotherapies usually used for treating lung cancer.

The at INER is mainly focused in patients with , a type of cancer that has the most alterations in its . It usually affects people of various ages, especially in people over 40, but has been known to affect the 20-something population.

Explore further: Clinical trial examines use of human immune system to fight aggressive lung cancer

Related Stories

Clinical trial examines use of human immune system to fight aggressive lung cancer

December 19, 2013
Researchers at the Cincinnati Cancer Center (CCC) and the UC Cancer Institute are conducting a clinical trial examining a method to stimulate the human immune system to destroy or block the growth of lung cancer cells.

Protein complex linked to cancer growth may also help fight tumors, researchers say

July 22, 2013
Researchers at Moffitt Cancer Center and Tianjin Medical University Cancer Institute and Hospital in China have discovered a gene expression signature that may lead to new immune therapies for lung cancer patients. They found ...

Researchers discover how cancer 'invisibility cloak' works

October 28, 2013
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, ...

Experimental drug shows encouraging results in treating most common form of lung cancer

November 1, 2013
An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among ...

Anti-tumor activity of immune cells can be restored

December 10, 2013
The Leuven-based VIB researchers have revealed a mechanism that explains why the anti-tumor activity of specific immune cells called macrophages is suppressed during tumor growth. They have also demonstrated that blocking ...

Key immune cell may play role in lung cancer susceptibility

September 21, 2012
(Medical Xpress)—Why do many heavy smokers evade lung cancer while others who have never lit up die of the disease? The question has vexed scientists for decades.

Recommended for you

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.